Duodenal-type follicular lymphoma a clinicopathologic review

Etan Marks, Yang Shi

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Duodenal-type follicular lymphoma (D-FL) is a newly recognized entity in the 2016 World Health Organization classification update. It has an immunophenotype similar to that of other FLs and usually carries the typical t(14;18)(q32;q21) translocation. However, unlike other FLs, D-FL is almost always diagnosed at a low stage and stays localized to the small intestine, most commonly the second portion of the duodenum, whereas the vast majority of other FLs are diagnosed at an advanced stage. Additionally, D-FL gene expression and pathogenesis appear to be more closely related to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue than to other types of FL. Therefore, many oncologists have opted to treat this variant of FL in a "watch and wait" manner because of its excellent prognosis and the rarity of D-FL to progress even when no treatments are attempted.

Original languageEnglish (US)
Pages (from-to)542-547
Number of pages6
JournalArchives of Pathology and Laboratory Medicine
Volume142
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Follicular Lymphoma
Marginal Zone B-Cell Lymphoma
Duodenum
Small Intestine
Gene Expression
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Duodenal-type follicular lymphoma a clinicopathologic review. / Marks, Etan; Shi, Yang.

In: Archives of Pathology and Laboratory Medicine, Vol. 142, No. 4, 01.04.2018, p. 542-547.

Research output: Contribution to journalReview article

@article{9c56f2a464554dd8a0c538abac47989c,
title = "Duodenal-type follicular lymphoma a clinicopathologic review",
abstract = "Duodenal-type follicular lymphoma (D-FL) is a newly recognized entity in the 2016 World Health Organization classification update. It has an immunophenotype similar to that of other FLs and usually carries the typical t(14;18)(q32;q21) translocation. However, unlike other FLs, D-FL is almost always diagnosed at a low stage and stays localized to the small intestine, most commonly the second portion of the duodenum, whereas the vast majority of other FLs are diagnosed at an advanced stage. Additionally, D-FL gene expression and pathogenesis appear to be more closely related to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue than to other types of FL. Therefore, many oncologists have opted to treat this variant of FL in a {"}watch and wait{"} manner because of its excellent prognosis and the rarity of D-FL to progress even when no treatments are attempted.",
author = "Etan Marks and Yang Shi",
year = "2018",
month = "4",
day = "1",
doi = "10.5858/arpa.2016-0519-RS",
language = "English (US)",
volume = "142",
pages = "542--547",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

TY - JOUR

T1 - Duodenal-type follicular lymphoma a clinicopathologic review

AU - Marks, Etan

AU - Shi, Yang

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Duodenal-type follicular lymphoma (D-FL) is a newly recognized entity in the 2016 World Health Organization classification update. It has an immunophenotype similar to that of other FLs and usually carries the typical t(14;18)(q32;q21) translocation. However, unlike other FLs, D-FL is almost always diagnosed at a low stage and stays localized to the small intestine, most commonly the second portion of the duodenum, whereas the vast majority of other FLs are diagnosed at an advanced stage. Additionally, D-FL gene expression and pathogenesis appear to be more closely related to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue than to other types of FL. Therefore, many oncologists have opted to treat this variant of FL in a "watch and wait" manner because of its excellent prognosis and the rarity of D-FL to progress even when no treatments are attempted.

AB - Duodenal-type follicular lymphoma (D-FL) is a newly recognized entity in the 2016 World Health Organization classification update. It has an immunophenotype similar to that of other FLs and usually carries the typical t(14;18)(q32;q21) translocation. However, unlike other FLs, D-FL is almost always diagnosed at a low stage and stays localized to the small intestine, most commonly the second portion of the duodenum, whereas the vast majority of other FLs are diagnosed at an advanced stage. Additionally, D-FL gene expression and pathogenesis appear to be more closely related to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue than to other types of FL. Therefore, many oncologists have opted to treat this variant of FL in a "watch and wait" manner because of its excellent prognosis and the rarity of D-FL to progress even when no treatments are attempted.

UR - http://www.scopus.com/inward/record.url?scp=85044526587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044526587&partnerID=8YFLogxK

U2 - 10.5858/arpa.2016-0519-RS

DO - 10.5858/arpa.2016-0519-RS

M3 - Review article

VL - 142

SP - 542

EP - 547

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -